Published in Am J Kidney Dis on February 01, 1997
Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N Am J Med Sci (2015) 0.90
Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag (2015) 0.85
An Interesting Case of Life-Threatening Hypercalcemia Secondary to Atypical Parathyroid Adenoma versus Parathyroid Carcinoma. Case Rep Med (2014) 0.81
The use of hemodialysis in refractory hypercalcemia secondary to parathyroid carcinoma. Case Rep Crit Care (2014) 0.75
Skin necrosis and protein C deficiency associated with vitamin K depletion in a patient with renal failure. Am J Med (1992) 2.04
Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med (1980) 1.69
Systemic lymphoblastic response to antithymocyte globulin in renal allograft recipients: an initial report. J Surg Res (1978) 1.60
Transjugular renal biopsy in patients with liver disease. Am J Kidney Dis (2001) 1.56
The chemical composition of faeces in uraemia, as revealed by in-vivo faecal dialysis. Clin Sci (1968) 1.53
Treatment of acute methanol intoxication with hemodialysis using an ethanol-enriched, bicarbonate-based dialysate. Am J Kidney Dis (1997) 1.43
Fungus infection in steroid-treated systemic lupus erythematosus. JAMA (1968) 1.39
Peritoneal fluid eosinophilia in patients undergoing maintenance peritoneal dialysis. Arch Intern Med (1981) 1.29
The effect of adrenal steroids on stool composition, as revealed by in vivo dialysis of faeces. Clin Sci (1969) 1.20
Hyperglycemia-induced hyponatremia: a fresh look. Clin Chem (1979) 1.16
Amantadine toxicity in a patient with renal insufficiency. Nephron (1974) 1.15
Toxic effects of amantadine in patients with renal failure. Can Med Assoc J (1979) 1.13
Pathophysiology of peritoneal fluid eosinophilia in peritoneal dialysis patients. Nephron (1999) 1.09
Ascites in patients treated with maintenance hemodialysis. Nephron (1974) 1.07
Nitric oxide synthase in circulating vs. extravasated polymorphonuclear leukocytes. J Leukoc Biol (1995) 1.03
Pseudolymphoma in renal allograft recipients. Arch Surg (1978) 1.00
Malignant lymphoma in a renal transplant recipient treated with antithymocyte globulin. Transplantation (1983) 1.00
Amantadine hydrochloride pharmacokinetics in hemodialysis patients. Ann Intern Med (1980) 1.00
Letter: Accumulation of amantadine hydrochloride in renal insufficiency. N Engl J Med (1974) 0.99
Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution. Perit Dial Int (1995) 0.98
Proximal forearm fistula for maintenance hemodialysis. Kidney Int (1977) 0.96
In vivo dialysis of faeces as a method of stool analysis. II. The influence of diet. Clin Sci (1967) 0.96
Splanchnic erythrocyte content decreases during hemodialysis: a new compensatory mechanism for hypovolemia. Kidney Int (1997) 0.93
Extreme hyperglycemia in dialysis patients. Clin Nephrol (1982) 0.93
Spurious hyperphosphatemia due to hyperlipidemia. Arch Intern Med (1985) 0.92
The posology of amantadine: a note of caution. JAMA (1980) 0.91
Peritoneal sclerosis in peritoneal dialysis patients. Am J Nephrol (1984) 0.89
A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol (1985) 0.89
Treatment of accidental hypothermia with peritoneal dialysis. Can Med Assoc J (1977) 0.89
In vivo dialysis of faeces as a method of stool analysis. 3. The effect of intestinal antibiotics. Clin Sci (1968) 0.89
First-use syndrome with cuprammonium cellulose dialyzers. Int J Artif Organs (1983) 0.88
Involvement of renal allograft by Fabry's disease. Am J Nephrol (1987) 0.88
"One-line" preparation of bicarbonate-containing dialysate for use in peritoneal dialysis. Int J Artif Organs (1981) 0.88
Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney Int (1978) 0.87
Penile calcification in maintenance hemodialysis patients. Urology (1992) 0.86
Serum tonicity, extracellular volume and clinical manifestations in symptomatic dialysis-associated hyperglycemia treated only with insulin. Int J Artif Organs (2004) 0.86
Renal allograft with massive perirenal accumulation of lymph. Br Med J (1969) 0.85
Hyperosmolar coma: cellular dehydration and the serum sodium concentration. Ann Intern Med (1989) 0.84
Hemodynamic effects of intradialytic food ingestion and the effects of caffeine. J Am Soc Nephrol (1993) 0.84
Acute renal failure complicating ruptured abdominal aortic aneurysm. Arch Surg (1975) 0.84
Calculi complicating a renal transplant. Am J Surg (1975) 0.83
Deafness after ethacrynic acid. Lancet (1969) 0.83
Metabolic alkalosis in a hemodialysis patient after ingestion of a large amount of an antacid medication. Artif Organs (2001) 0.83
Parathyroid hyperfunction in acute renal failure. Serial studies in man. Nephron (1972) 0.83
First-use reactions during hemodialysis: a definition of subtypes. Kidney Int Suppl (1988) 0.82
Colon-cancer screening in dialysis patients. Artif Organs (1990) 0.82
Hypercalcaemia in acute renal failure of acute alcoholic rhabdomyolysis. S Afr Med J (1972) 0.82
Laboratory monitoring of pentasaccharide in a dog model of hemodialysis. Thromb Res (1999) 0.82
Legionnaires' disease bacillus in bone marrow. Can Med Assoc J (1981) 0.81
Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J (2001) 0.81
Kinetics of peritoneal fluid absorption in patients with chronic renal failure. J Lab Clin Med (1980) 0.81
Fanconi syndrome associated with a non-ossifying fibroma of bone. Am J Med (1985) 0.81
Glomerular ultrastructural abnormalities in a patient with mixed IgG-IgM essential cryoglobulinemic glomerulonephritis. Nephron (1975) 0.80
Cerebrospinal fluid changes in experimental cardiopulmonary bypass using hemodilution with glucose water. Neurology (1977) 0.80
Studies of the vasorelaxant effect of acetate. Trans Am Soc Artif Intern Organs (1984) 0.80
Initial results of a new access device for hemodialysis technical note. Kidney Int (1998) 0.80
Induction of peritoneal fluid eosinophilia and/or monocytosis by intraperitoneal air injection. Am J Nephrol (1987) 0.80
Hemodynamic response to volume depletion in acutely uremic dogs. Am J Physiol (1984) 0.80
In vitro binding of amantadine to plasma proteins. Clin Neuropharmacol (1984) 0.80
Severe anaphylactoid reactions to cuprammonium cellulose hemodialyzers. Arch Intern Med (1985) 0.80
Hemodialysis as a treatment of severe ethanol poisoning. Int J Artif Organs (1999) 0.79
Total hip replacement in patients with renal transplants. Arch Surg (1983) 0.79
Subxiphoid pericardiostomy for hemodialysis-associated pericardial effusion. Arch Intern Med (1986) 0.79
Amantadine hydrochloride pharmacokinetics in patients with impaired renal function. Clin Nephrol (1982) 0.79
Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG? Transplant Proc (1979) 0.79
Variation in blood sample collection for determination of hemodialysis adequacy. Council on Renal Nutrition National Research Question Collaborative Study Group. Am J Kidney Dis (1998) 0.79
Effect of dialysate temperature on central hemodynamics and urea kinetics. Kidney Int (1995) 0.79
Post to predialysis plasma urea nitrogen ratio, ultrafiltration and weight to estimate K.t/V. Use in auditing the amount of dialysis being administered. ASAIO Trans (1990) 0.78
Return of function in the thrombosed kidney after transplantation. Nephron (1977) 0.78
Predictive value of active T-RFC in renal allograft survival. Transplant Proc (1978) 0.78
Development of a new approach to vascular access. Artif Organs (1999) 0.78
Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate. Am J Kidney Dis (2000) 0.78
Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Artif Organs (1992) 0.78
Dose-response relationship in angiotensin bioassay. Cardiovasc Res (1968) 0.78
Adverse effects of dialyzers manifesting during the dialysis session. Nephrol Dial Transplant (1994) 0.78
Severe reactions to Cuprophan capillary dialyzers. Artif Organs (1982) 0.78
Effects of hypertonic peritoneal dialysis solutions on neutrophil superoxide production. Artif Organs (1990) 0.78
Hemodialysis ascites in anephric patients. Clin Nephrol (1981) 0.78
Ultrafiltration control during continuous arteriovenous hemodialysis using paired volumetric dialysate pumps. Int J Artif Organs (1986) 0.77
Protein-calorie malnutrition and cutaneous anergy in hemodialysis maintained patients. Am J Clin Nutr (1980) 0.77
Demonstration of Fabry's disease deposits in placenta. Am J Obstet Gynecol (1990) 0.77
Classification of first-use reactions. Int J Artif Organs (1986) 0.77
Serum potassium and acid-base parameters in severe dialysis-associated hyperglycemia treated with insulin therapy. Int J Artif Organs (2005) 0.77
Continuous arteriovenous hemodialysis. Int J Artif Organs (1985) 0.77
Phosphorus-enriched hemodialysis for the treatment of patients with severe methanol intoxication. Int J Artif Organs (2005) 0.77
Treatment of refractory hemodialysis ascites with maintenance peritoneal dialysis. Clin Nephrol (1981) 0.77
Ketoconazole in the treatment of recurrent nephrolithiasis associated with sarcoidosis. Nephrol Dial Transplant (1994) 0.76
Preparation of ethanol-enriched, bicarbonate-based hemodialysates. Artif Organs (1999) 0.76
Pancreatic transplantation for diabetes mellitus. IMJ Ill Med J (1973) 0.76
IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis. J Allergy Clin Immunol (1985) 0.76
Prolonged hypernatremia associated with azotemia and hyponatriuria. Am J Med (1989) 0.76
Transplantation in and of the young. J Urol (1974) 0.76
Saline-induced dilutional acidosis in a maintenance hemodialysis patient. Int J Artif Organs (1999) 0.75
Chylous ascites in a patient treated with intermittent peritoneal dialysis. Artif Organs (1984) 0.75
Blood eosinophilia in patients undergoing maintenance peritoneal dialysis. Arch Intern Med (1985) 0.75
Transdermal clonidine for hypertensive patients. Clin Ther (1983) 0.75
Removal of amantadine hydrochloride by dialysis in patients with renal insufficiency. Can Med Assoc J (1976) 0.75
Use of a phosphorus-enriched dialysis solution to hemodialyze a patient with lithium intoxication. Artif Organs (1995) 0.75
Lymphocyst following renal transplantation. Can Med Assoc J (1971) 0.75
Erythropoietin ameliorates anemia of cisplatin induced acute renal failure. ASAIO J (1998) 0.75